Curriculum Vitae (C.V.) of Prof. Dr. Hamid Sattar: Vice-President Clinical Sciences & Professor at IUSOM - Michigan Clinical Campus in Dearborn, Michigan, USA
CURRICULUM VITAE (C.V.) Prof. Dr. Hamid Sattar, M.D., FACC, FSCAI
2013 - Present: International University School of Medicine (IUSOM) - Michigan Clinical Campus, Dearborn, Michigan, USA Vice-President Clinical Sciences & Professor Clinical Rotations for Doctor of Medicine (M.D.) Degree and Clinical Training for Post Graduate Diploma in Clinical Cardiology (PGDCC) & for Masters in Clinical Cardiology (MCC) Programs for IUSOM's students
7/2008 - Present: Detroit Medical Center (DMC), Detroit, Michigan, USA Chief Cardiovascular Imaging Director of Cardiac CT Angiography Director of Cardiac MRI Director of Cardiac PET/ CT Director of Nuclear Cardiology DMC CardioTeamOne-Interventional Cardiologist Advanced Cardiac Imaging Fellowship Program Director DMC/Wayne State University, Detroit, Michigan, USA
2012 - Present: ARK Medical Group, Detroit, Michigan, USA Chief Cardiovascular Medicine Director of Echocardiography Director of Vascular Laboratory
7/2007 - 6/2008: Detroit Medical Center Wayne State University, Detroit, Michigan, USA Endovascular Interventional Cardiology Fellow
7/2006- 6/2007: Brigham and Women's Hospital Harvard Medical School, Boston, MA, USA Advanced Cardiac and Vascular Imaging Fellow
7/2003 - 6/2006: Detroit Medical Center Wayne State University, Detroit, Michigan, USA Adult Cardiology Fellow
7/2000 - 6/2003: Detroit Medical Center Wayne State University, Detroit, Michigan, USA Internal Medicine Residency
1/1998-2001: Midwest Physical Therapy, Ypsilanti, Michigan, USA President/CEO Primary investor and operator of clinic providing physical therapy and rehabilitation services.
1994-1996: Downriver Physical Therapy, Lincoln Park, Michigan, USA Senior Administrator Managed daily clinic operations, payroll, and schedule of employees.
EDUCATION
1995-2000: M.D., Michigan State University, East Lansing, Michigan, USA
1992-1995: B.S. Biology, Wayne State University, Detroit, Michigan, USA
ACCREDITATIONS
ABIM Internal Medicine Certification 2004
ABIM General Cardiology Certification 2008
Certification of Board of Nuclear Cardiology 2008
American Society of Echocardiography Certification 2008
WSU/DMC representative for Fellows in Training Council for the Michigan Chapter Of ACC in 2004
2nd Place Poster Presentation 2001 Michigan Chapter of ACP
Co-author of $50,000 grant from Fujisawa with Dr. Edouard Daher: Correlation between Adenosine SPECT imaging and FFR in angiographic intermediate lesions in 2000
Intern of the Year WSU/DMC 2000
Elected Class Representative for Residents Administrative Council from 2000- 2003.
Phi Beta Kappa Honor Society 1995
Graduated Magna Cum Laude 1995
PUBLICATIONS / PRESENTATIONS
Impella Assisted Left Main Interventions. Mirvat Alsanag M.D., Hamid Sattar M.D., and Theodore Schreiber M.D. Oral Presentation. Dubai International Cardiology Conference 2009
Hamid Sattar M.D. Coronary CT Angiography: The Present and Future Interventional Cardiology Grand Rounds Presentation. Detroit Medical Center at Wayne State University 2009
Raymond Y. Kwong, Hamid Sattar, Henry Wu, Gabriel Vorobiof, Vijay Gandla, Kevin Steel, Samuel Siu, and Kenneth A. Brown Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial Infarction Circulation 2008: Published online before print August 25, 2008, 10.1161/CIRCULATIONAHA.107.727826.
High Resolution Cardiovascular Magnetic Resonance Imaging of Carotid Arteries Reliably Detects Very Significant Early Atherosclerosis in Patients with Elevated LP(a). Hamid Sattar M.D., Kim Christian, Mary P. Harmon, H. Robert Superko, and Szilard Voros M.D. (SCMR Oct. 2006)
Delayed Enhancement on Cardiac MRI Reliably Predicts Increased Risk of Morbidity and Mortality Among Diabetics without Clinical History of Myocardial Infarction. Hamid Sattar M.D., Vijay Gandla M.D., Raymond Y. Kwong M.D. (SCMR Oct. 2006)
A Positive Rest-Stress Myocardial Perfusion SPECT Defect Is Not Always CAD. Coronary Cameral Fistula Causing Coronary Steal Phenomenon. Haroon Farooz M.D., Hamid Sattar M.D., Peter Vaitkevicius M.D. Poster Presentation WSU Research Conference. Detroit, MI. 2006.
West Nile Virus Encephalitis. Hamid Sattar M.D. and Neel Patel M.D., Poster Presentation. ACP National Meeting, San Diego, CA. 2003.
Colon Cancer presenting with Paraplegia. Hamid Sattar M.D. and Karl Duncan M.D. Poster Presentation. ACP Michigan chapter, Traverse, MI 2002.
Zinc Induced Iron Deficiency Anemia. Hamid Sattar M.D., Joel Garcia M.D., and Neel Patel M.D. Poster Presentation. SGIM Midwest chapter, Chicago, Ill. 2001.
Hybrid Zones of Species Differentiation. Hamid Sattar, Chin Min Yuan PhD., and Karl F. Freeman PhD. Poster Presentation. American Society of Ecology, Chicago, Ill. 1996.
RESEARCH
CLINICAL TRAILS:
RESOLUTE US Clinical Trial - A Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm." Primary Investigator. 2009-Present
GORE EMBOLIC Filter in Carotid Stenting for High Risk Surgical Subjects (GORE EMBOLDEN) - Sponsor: W. L. Gore & Associates Co-Investigator. 2009-Present
DEFINITIVE Ca(2+) - Determination 'of Safety and Effectiveness of the Silverhawk ® Peripheral Plaque Excision System for Calcium (Silverhawk LS-C) and the SpiderFX EmbolicTM Protection Device (SpiderFX) for the Treatment of Calcified Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries, Protocol No.: FHT-P- 07-003. Sponsor: ev3, Inc. Co-Investigator 2009- Present
PAREXEL International - A Multicenter, Randomized, Double-blind placebo-controlled staggered dose-escalating phase IIb study of the safety and efficacy of istaroxime over 24 hours at three doses in acute decompensated heart failure patients. Sub-Investigator. 2009- Present
RED-HF Trial - Reduction of events with Darbepoetin alfa in Heart Failure Trial. Trial of study: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia. Sub-Investigator. 2009- Present
TOPCAT - Treatment of Preserved Cardiac function heart failure with an Aldosterone an Tagonist. Protocol: Constantina Alexandris-Souphis. Sub-Investigator. 2009- Present
THE BALANCE STUDY - Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation. Sponsor: Cardiokine Biopharma, LLC and Biogen Idec, INC. Protocol number: CK-LX3401. Investigator. 2009- Present
BOREALIS - A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority study comparing the efficacy and safety of Once-weekly subcutaneous Biotinylated Idrabiotaparinux (SSR126517E) with oral adjusted-dose Warfarin in the prevention of stroke and systemic thromboembolic events in patients with Atrial Fibrillation; Borealis: EFC10295. Sub-Investigator. 2009- Present
CAPTURE 2 - A Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems (Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events "CAPTURE 2") Protocol 05-716, Amendment to CAPTURE 04-715. Sub-Investigator. 2008-Present
SAPPHIRE WW - Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy, Protocol Number P06- 3603. Co-Investigator. 2008-Present
CHOICE - Carotid Stenting For High Surgical Risk Patients; Evaluating Outcomes Through The Collectlon Of Clinical Evidence ("CHOICE"), Protocol No.: 06-717. Co-Investigator. 2007-Present
APEX-AMI - Assessment of PEX elizumab in Ami Co. Investigator. 2005-Present
PERISCOPE - Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation. Sub Investigator. 2005-Present
AMIHOT II - Acute Myocardial Infarction with HyperOxemic Therapy II. Sub-Investigator. 2005-Present
________________________________________________
IUSOM Main Campus and Headquarters
International University School of Medicine Kaya Mòfi 1 P. O. Box # 59 Kralendijk, Bonaire, Caribbean Netherlands (Dutch Caribbean) 0000BQ The Netherlands, European Union (EU) Telephone: + 599 - 717 - 6792 Fax: + 599 - 717- 8385 CRIB (Tax) Number at Caribisch Nederland Belastingdienst: 303056514 info@InternationalUniversity-SchoolOfMedicine.org
All information is deemed reliable but is not guaranteed and should be verified by the viewer.